Cuvo Health charges a flat monthly fee, a $9,800 or $15,000 setup fee, and $25 per completed consult, with no cut of sales. FUSE charges $5,600 or $30,000 upfront, no per-visit fees, and a 2% merchant fee. Which costs less depends on order size and consult volume.
Disclosure: FUSE wrote this page and is one of the two platforms compared. Every Cuvo Health figure links to the Cuvo page it came from, so you can check it yourself. If you represent Cuvo Health and something here is out of date, tell us and we'll correct it.
Executive Summary
Cuvo Health ranks FUSE second on its own list of white-label peptide platforms, then tells readers FUSE doesn't publish its onboarding fee. That line is out of date. The FUSE pricing page lists every fee: $5,600 on Growth (first month included) and $30,000 on Partner (first 12 months included). Cuvo's own head-to-head page, updated November 14, 2026, now says the same. Its peptide listicle still carries the September 30 wording.
The fee Cuvo leads with is real, though. FUSE takes 2% of each patient payment on Growth and Partner. Cuvo Health takes no percentage and charges $25 per completed consult instead.
So the real question is which fee model costs less for your order size and consult frequency. This page runs that math at three revenue levels and shows every assumption.
Short version: FUSE fits peptide-first and GLP-1 brands that want to launch in days with little upfront cost. Cuvo Health fits brands with high-ticket orders, several specialties, or a need for the vendor to build and run the medical entity.
FUSE vs Cuvo Health at a Glance
Cuvo figures come from cuvo.co/pricing, its provider network page and its terms; FUSE figures come from fusehealth.com.
| Factor | FUSE | Cuvo Health | Checked on |
|---|---|---|---|
| What it is | White-label telehealth platform: your storefront, with clinician review and pharmacy routing running behind it | White-label platform plus an operated clinic; Cuvo builds an MSO and physician-owned entity for you | Nov 18, 2026 |
| Upfront fee | $5,600 (Growth), $30,000 (Partner) | $9,800 (Launch), $15,000 (Grow), custom (Enterprise) | Nov 18, 2026 |
| Monthly platform fee | $699 (Growth, from month 2); $3,000 on Partner from month 13 | $997 (Launch), $2,500 (Grow) | Nov 18, 2026 |
| Per-consult fee | None | $25 per completed consult | Nov 18, 2026 |
| Cut of each sale | 2% (Growth, Partner) merchant service fee | None; standard card processing applies | Nov 18, 2026 |
| Programs | 70 visit types across 11 categories, including GLP-1, peptides, hormones and TRT | Seven categories; TRT needs Grow or above (EPCS) | Nov 18, 2026 |
| Pharmacy | 503A and 503B network; bring a qualified pharmacy on Partner | Unnamed 503A partner pharmacies; bring your own on every plan | Nov 18, 2026 |
| Clinicians | Independent licensed MDs, DOs and NPs in all 50 states; under 24-hour average review | 300+ physicians, NPs and PAs in all 50 states (Cuvo figure as of Sept 2, 2026) | Nov 18, 2026 |
| LegitScript | Certified; expedited coordination included on Growth and Partner | Certified since Oct 16, 2026; expedited on Grow and above | Nov 18, 2026 |
| Stated launch time | 3 to 5 business days | Typically under 30 days | Nov 18, 2026 |
| Developer access | Public API and AI (MCP) connector on every plan | No API or CRM sync on Launch | Nov 18, 2026 |
What Cuvo Health and FUSE Each Are
Cuvo Health
Cuvo Health is a white-label telehealth platform run by Medstra Inc., a Delaware company that operated as Medstra before the rebrand. Brands sell under their own name while Cuvo supplies the clinician network, partner pharmacies, intake software and the medical entity behind the brand. It serves GLP-1, testosterone and hormone, peptide, sexual health, women's health, wellness and hair loss programs, and charges a flat platform fee plus $25 per completed consult.

FUSE
FUSE is a white-label telehealth platform for operators who don't hold a medical license: e-commerce brands, med spas, gyms, coaches, creators and health apps. You run the storefront and the marketing. Independent licensed clinicians review each intake, and prescriptions route to a pharmacy that ships under your brand. FUSE reports more than 1,200 programs launched and 94% refill retention on its homepage, and charges a monthly platform fee plus a 2% merchant fee, with no per-visit fees.
The core difference: Cuvo Health sells an operated clinic with per-consult pricing. FUSE sells the operating system for a branded program, with pricing tied to sales.
FUSE vs Cuvo Health Pricing at Three Monthly Revenue Levels
A percentage fee follows revenue. A per-consult fee follows how often a clinician signs off. You need both numbers to compare them.
The assumptions behind the math
- Patient payment: $250 a month per active patient. Swap in your own price.
- Revenue levels: $15,000, $50,000 and $150,000 a month (60, 200 and 600 active patients).
- Consults: your clinical protocol and state rules set how often patients need one, not the platform. We show two cases: one consult per patient every month, and one every three months.
- Plans: FUSE Growth against Cuvo Launch, the guided entry tier on each side. We add FUSE Partner and Cuvo Grow to the year-one table.
- Left out for both: medication, shipping, labs, card processing, LegitScript's own fees and add-ons. Revenue is flat from month one; real launches ramp up.
Monthly platform cost from month 2
| Monthly revenue | FUSE Growth ($699 + 2%) | Cuvo Launch, monthly consults | Cuvo Launch, quarterly consults |
|---|---|---|---|
| $15,000 (60 patients) | $999 | $2,497 | $1,497 |
| $50,000 (200 patients) | $1,699 | $5,997 | $2,672 |
| $150,000 (600 patients) | $3,699 | $15,997 | $5,997 |
Year-one cost including setup
| Plan | $15,000/mo | $50,000/mo | $150,000/mo |
|---|---|---|---|
| FUSE Growth ($5,600 + 11 x $699 + 2%) | $16,889 | $25,289 | $49,289 |
| FUSE Partner ($30,000 + 2%) | $33,600 | $42,000 | $66,000 |
| Cuvo Launch, monthly consults | $39,764 | $81,764 | $201,764 |
| Cuvo Launch, quarterly consults | $27,764 | $41,864 | $81,764 |
| Cuvo Grow, quarterly consults | $51,000 | $65,100 | $105,000 |
The Cuvo Launch base of $21,764 ($9,800 setup plus 12 months at $997) matches the figure Cuvo publishes on its Fuse Health alternatives post.
Costs that sit outside the platform fee
The tables above cover platform fees only. These line items can move your real budget more than the platform fee does.
| Cost | FUSE | Cuvo Health |
|---|---|---|
| Medication and shipping | Charged by the pharmacy per order | Charged by the partner pharmacy per order, shipping billed per order |
| Live video visits | No per-visit fees | Billed per visit where a state or controlled-substance rule requires video |
| Card processing | May apply separately from the merchant fee | Standard card processing on your own merchant account |
| LegitScript | Coordination included on Growth and Partner | Expedited on Grow and above; LegitScript's own application and annual fees extra |
| Website build | Complete website on Partner | Full website buildout on Grow and above |
| Common add-ons | Branded pharmacy packaging (Partner) | Branded app $4,999 a year; Cuvo AI+ analytics $499 a month |
Where Cuvo Health's model wins the math
A 2% fee costs more than a $25 consult once a single consult covers more than $1,250 in patient payments. You cross it when orders are large and consults are rare: annual prepaid plans, high-priced hormone or longevity packages, or protocols where one consult covers many months of refills.
If that's your brand, Cuvo Health pricing can beat FUSE. Below that line, FUSE cost less in every scenario above. Cuvo is candid about its own floor too: its pricing page says brands below "a few hundred patients a month" in year one rarely earn back the setup fee.
That's the real cuvo vs fuse decision: your average order size against your consult frequency, not the sticker fees.
Peptide and GLP-1 Programs on FUSE and Cuvo Health

Both platforms serve peptide and weight-loss brands. They differ in how much of the catalog they publish.
Peptides
FUSE was built around peptides. Its peptide telehealth platform covers five program categories: weight loss and metabolic, recovery and repair, hormone and longevity, sexual health, and skin, hair and immune. Everything ships as prescription-grade product, never research-use-only. A brand that brings its own pharmacy on Partner must use one that is licensed in every state it serves, LegitScript certified and PCAB accredited for compounding.
Cuvo Health "publishes no fixed peptide catalog" but names six peptides covered by the October 2026 HHS enforcement policy: BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon. Each is a single-ingredient prescription filled by a 503A partner pharmacy. Blends, pen injectors, 503B facilities and research-use-only supply are excluded, and partner pharmacies aren't named.
Cuvo's own general platform listicle calls FUSE "best for peptide-first brands." To see what the new policy allows, read FUSE's breakdown of peptide compounding under the HHS policy.
GLP-1 programs
Both platforms support compounded semaglutide and tirzepatide programs. Neither one removes the legal risk. The FDA declared the tirzepatide and semaglutide shortages resolved, which narrows when pharmacies may compound copies of approved drugs. Your pharmacy's 503A or 503B status shapes what it can ship and to whom; FUSE's 503A vs 503B guide covers the difference.
One plan detail: Cuvo excludes testosterone on Launch, because it needs electronic prescribing for controlled substances (EPCS), which starts on Grow.
This section describes what each platform supports for operators. It isn't medical advice. Licensed clinicians make every prescribing decision on both platforms.
How Each Platform Runs the Clinic and Compliance
Cuvo Health builds and operates the medical entity
Cuvo sets up and maintains a management services organization (MSO) and a physician-owned professional entity for each brand, which matters in states with corporate practice of medicine rules. Cuvo's own September 2026 report counts 33 of 51 jurisdictions that restrict it. It also screens clinicians monthly against federal exclusion lists, includes malpractice coverage, and lists SOC 2 Type II and a HIPAA business associate agreement on every plan.
Read the contract as closely as the marketing. Cuvo's terms call it "a technology services provider" that "does not employ or control the providers." They name your brand the covered entity, make you "solely responsible" for provider licensing (section 5.1), and cap Cuvo's liability at 12 months of fees. Terms like these are common; know them before you sign.
FUSE runs the workflow behind your storefront
FUSE doesn't prescribe, and you don't need a medical license. Here's how it works:
- You build your storefront and choose programs from templates, or build with the AI connector.
- A patient checks out and completes intake under your brand.
- An independent licensed clinician reviews every intake. FUSE's stated average is under 24 hours.
- Approved prescriptions route to a pharmacy that ships under your brand.
- Stripe billing, refills, HIPAA consent flows and claims guardrails run in the background.
LegitScript certification decides whether Google will run your ads for prescription drugs, so FUSE coordinates the application on Growth and Partner. Past FUSE-coordinated applications averaged about 11 days. LegitScript decides every application on its own, so that timing isn't guaranteed. The full process is in FUSE's LegitScript certification guide, and state-by-state ownership rules are in the corporate practice of medicine guide.
Where Cuvo publishes more: a clinician headcount and a detailed MSO structure. FUSE doesn't publish a prescriber headcount. If your investors need those documents, ask both vendors on the first call.
Launch Speed and What Actually Slows It Down
FUSE states 3 to 5 business days to a live storefront, and as little as 3 days on Partner once the prerequisites are in place. Cuvo Health states "typically under 30 days" for its operated clinic, and under a week for Cuvo Prescribe, where you bring your own EHR.
The gap comes from what each vendor builds. Cuvo forms and credentials a medical entity for you, which takes paperwork time. FUSE plugs your storefront into a clinician and pharmacy workflow that already exists.
On either platform, three things usually slow a launch more than the software:
- LegitScript review. Without it, Google and Meta won't run your prescription ads, and approval timing sits with LegitScript, not the vendor.
- Pharmacy licensing by state. A pharmacy can only ship where it holds a license, so a narrow footprint limits your launch states. FUSE explains why programs stall here in its telehealth pharmacy licensing guide.
- Your own claims review. Product pages that promise outcomes get flagged by payment processors and ad platforms. Clean copy up front saves weeks.
Questions to Ask Both Vendors Before You Sign
Bring these to each sales call. Ask for every answer in writing.
- Which medical group or clinicians will prescribe for my patients, and who employs them?
- Which pharmacies will fill my orders, in which states, and are they 503A or 503B?
- How often does my protocol require a consult, and what does each one cost me?
- Who owns patient records, subscription data and payment tokens if I leave?
- Can you send your SOC 2 report, BAA and current LegitScript listing before I sign?
Whichever vendor answers all five clearly is the one that will hold up when you scale.
Who Should Choose FUSE and Who Should Choose Cuvo Health

Choose FUSE if
- You're launching a peptide-first or GLP-1 brand and want to be live in 3 to 5 business days on a white-label telehealth platform built for operators without a medical license.
- You want to test before you pay: a free sandbox, then $5,600 on Growth with expedited LegitScript included.
- Your average order sits below $1,250 per consult, or your protocol needs frequent check-ins. FUSE charges no per-visit fees.
- Your team wants the FUSE API and AI connector from the first plan.
Choose Cuvo Health if
- Your orders are large and consults are rare, so a flat $25 beats a percentage.
- You want the vendor to build and maintain your MSO and professional entity, with published network and SOC 2 documentation.
- You run several specialties, need TRT with EPCS, or want a branded mobile app ($4,999 a year).
- You already have clinicians or an EHR and want Cuvo Prescribe to plug in its pharmacy and providers.
The Bottom Line
Both platforms publish their prices now, so the choice comes down to arithmetic and operating model. If patients pay a few hundred dollars a month and see a clinician often, the 2% fee costs less than a per-consult fee, and FUSE gets you selling sooner with less upfront. If orders run into four figures per consult, or you want the vendor to own the medical entity paperwork, Cuvo Health is the stronger fit. Run your own numbers before you sign either contract.
Still comparing? See FUSE vs MyOrbitHealth, FUSE vs Karpa Health, other platforms to compare with FUSE, and our white-label telehealth platform roundup.
References
- FUSE pricing (checked Nov 18, 2026)
- FUSE, How FUSE Works (checked Nov 18, 2026)
- Cuvo Health pricing, "pricing facts last reviewed Oct 26, 2026" (checked Nov 18, 2026)
- Cuvo Health, Cuvo vs Fuse Health, updated Nov 14, 2026 (competitor-authored)
- Cuvo Health, Best white label peptide platforms (checked Nov 18, 2026)
- Cuvo Health, Best white label telehealth platforms, updated Nov 14, 2026
- Cuvo Health, Fuse Health alternatives (checked Nov 18, 2026)
- Cuvo Health, provider network, figures as of Sept 2, 2026
- Cuvo Health, terms of service (checked Nov 18, 2026)
- Cuvo Health, HHS peptide policy (checked Nov 18, 2026)
- PR Newswire, Cuvo Health 2026 state-by-state virtual clinic compliance report, Sept 27, 2026
- U.S. FDA, FDA's concerns with unapproved GLP-1 drugs used for weight loss
- Google Ads policy, Healthcare and medicines



